Association of Milk Consumption with the Incidence of Cholelithiasis Disease in the US Adult Population

Overview

Journal BMC Public Health

Publisher Biomed Central

Specialty Public Health

Date 2023 Aug 27

PMID 37635228

Authors

Feng Jia

Yu Ma

Yahui Liu

Affiliations

Soon will be listed here.

Abstract

Background: Cholelithiasis is a common digestive system disease that imposes major burden on patients and society. Investigating the relationship between dietary factors and cholelithiasis risk can provide a basis for disease prevention. Previous studies on milk intake and cholelithiasis incidence have been limited.Therefore, the aim of our study was to assess the association between milk consumption and the incidence of cholelithiasis in males and females.

Methods: We selected 14,722 adults (≥ 18 years old) from National Center for Health Statistics (NHANSE) 2017-2020, and collected general characteristics of patients in the database, such as age, gender, race and body mass index (BMI), as well as dietary information (milk consumption). The occurrence of cholelithiasis was used as the outcome event, and the group was divided into cholelithiasis and non-cholelithiasis groups according to the outcome event. We used logistic regression models in generalized linear model (GLM) functions, controlling for demographic, lifestyle, and dietary factors, to estimate the association between milk intake and the incidence of cholelithiasis in males and females.

Results: A total of 14,722 adults were included. In the present study, the overall weighted prevalence of cholelithiasis was 10.96%, with 15.18% and 6.48% prevalence in females and males, respectively. Compared to infrequent milk intake, frequent milk intake (once a week or more) in females was associated with reduced cholelithiasis risk (OR 0.74, 95% CI 0.61-0.90). Daily milk intake in males was also related to lower cholelithiasis risk (OR 0.69-0.82). As adjusted variables increased in the models, predictive performance was improved (AUC 0.711 in females, 0.730 in males).

Conclusions: Appropriate milk intake may correlate with decreased cholelithiasis risk. Our study provides a basis for dietary interventions against gallstones, but prospective studies are needed to verify the results.

Citing Articles

The Causal Relationship Between Choline Metabolites and Acute Acalculous Cholecystitis: Identifying as Colocalized Gene.

Gao Y, Mao K, Yang C, Wang X, Liu S, Ma Z Nutrients. 2024; 16(21).

PMID: 39519421 PMC: 11547454. DOI: 10.3390/nu16213588.

Dietary patterns, genetic predisposition, and risk of cholelithiasis: a large-scale prospective cohort study.

Jin K, Mi N, He W, Zhong R, Jin B, Liu Z Front Nutr. 2024; 11:1469789.

PMID: 39399528 PMC: 11466834. DOI: 10.3389/fnut.2024.1469789.

Association between life-ever gallstones and depressive symptoms in U.S. adults: a cross-sectional study.

Pan T, Zhang C, Liang J, Wang X, Di X, Zhou Y Sci Rep. 2024; 14(1):18845.

PMID: 39143232 PMC: 11325026. DOI: 10.1038/s41598-024-69777-7.

References

OConnell K, Brasel K . Bile metabolism and lithogenesis. Surg Clin North Am. 2014; 94(2):361-75. DOI: 10.1016/j.suc.2014.01.004. View

Amaral J, Thompson W . Gallbladder disease in the morbidly obese. Am J Surg. 1985; 149(4):551-7. DOI: 10.1016/s0002-9610(85)80055-6. View

Weinsier R, Wilson L, Lee J . Medically safe rate of weight loss for the treatment of obesity: a guideline based on risk of gallstone formation. Am J Med. 1995; 98(2):115-7. DOI: 10.1016/S0002-9343(99)80394-5. View

Lammert F, Gurusamy K, Ko C, Miquel J, Mendez-Sanchez N, Portincasa P . Gallstones. Nat Rev Dis Primers. 2016; 2:16024. DOI: 10.1038/nrdp.2016.24. View

Portincasa P, Moschetta A, Palasciano G . Cholesterol gallstone disease. Lancet. 2006; 368(9531):230-9. DOI: 10.1016/S0140-6736(06)69044-2. View

Mendez-Sanchez N, Chavez-Tapia N, Motola-Kuba D, Sanchez-Lara K, Ponciano-Rodriguez G, Baptista H . Metabolic syndrome as a risk factor for gallstone disease. World J Gastroenterol. 2005; 11(11):1653-7. PMC: 4305948. DOI: 10.3748/wjg.v11.i11.1653. View

Buch S, Schafmayer C, Volzke H, Becker C, Franke A, von Eller-Eberstein H . A genome-wide association scan identifies the hepatic cholesterol transporter ABCG8 as a susceptibility factor for human gallstone disease. Nat Genet. 2007; 39(8):995-9. DOI: 10.1038/ng2101. View

Maurer K, Rao V, Ge Z, Rogers A, Oura T, Carey M . T-cell function is critical for murine cholesterol gallstone formation. Gastroenterology. 2007; 133(4):1304-15. PMC: 2043485. DOI: 10.1053/j.gastro.2007.07.005. View

Weikert C, Weikert S, Schulze M, Pischon T, Fritsche A, Bergmann M . Presence of gallstones or kidney stones and risk of type 2 diabetes. Am J Epidemiol. 2010; 171(4):447-54. DOI: 10.1093/aje/kwp411. View

10.

Di Ciaula A, Garruti G, Fruhbeck G, De Angelis M, de Bari O, Wang D . The Role of Diet in the Pathogenesis of Cholesterol Gallstones. Curr Med Chem. 2017; 26(19):3620-3638. PMC: 8118138. DOI: 10.2174/0929867324666170530080636. View

11.

Everhart J . Contributions of obesity and weight loss to gallstone disease. Ann Intern Med. 1993; 119(10):1029-35. DOI: 10.7326/0003-4819-119-10-199311150-00010. View

12.

Gutierrez-Diaz I, Molinero N, Cabrera A, Rodriguez J, Margolles A, Delgado S . Diet: Cause or Consequence of the Microbial Profile of Cholelithiasis Disease?. Nutrients. 2018; 10(9). PMC: 6163750. DOI: 10.3390/nu10091307. View

13.

Valdivieso V, Covarrubias C, Siegel F, Cruz F . Pregnancy and cholelithiasis: pathogenesis and natural course of gallstones diagnosed in early puerperium. Hepatology. 1993; 17(1):1-4. View

14.

Lammert F, Sauerbruch T . Mechanisms of disease: the genetic epidemiology of gallbladder stones. Nat Clin Pract Gastroenterol Hepatol. 2005; 2(9):423-33. DOI: 10.1038/ncpgasthep0257. View

15.

Ko C, Beresford S, Schulte S, Lee S . Insulin resistance and incident gallbladder disease in pregnancy. Clin Gastroenterol Hepatol. 2007; 6(1):76-81. PMC: 2693050. DOI: 10.1016/j.cgh.2007.10.007. View

16.

Stokes C, Krawczyk M, Lammert F . Gallstones: environment, lifestyle and genes. Dig Dis. 2011; 29(2):191-201. DOI: 10.1159/000323885. View

17.

Marzio L . Factors affecting gallbladder motility: drugs. Dig Liver Dis. 2003; 35 Suppl 3:S17-9. DOI: 10.1016/s1590-8658(03)00088-4. View

18.

Nervi F, Miquel J, Alvarez M, Ferreccio C, Garcia-Zattera M, Gonzalez R . Gallbladder disease is associated with insulin resistance in a high risk Hispanic population. J Hepatol. 2006; 45(2):299-305. DOI: 10.1016/j.jhep.2006.01.026. View

19.

Ye F, Shen H, Li Z, Meng F, Li L, Yang J . Influence of the Biliary System on Biliary Bacteria Revealed by Bacterial Communities of the Human Biliary and Upper Digestive Tracts. PLoS One. 2016; 11(3):e0150519. PMC: 4773253. DOI: 10.1371/journal.pone.0150519. View

20.

Festi D, Villanova N, Colecchia A . Risk factors for gallstone formation during weight loss. Clin Gastroenterol Hepatol. 2014; 13(3):613. DOI: 10.1016/j.cgh.2014.08.010. View